This report provides exclusive insights into the COVID-19 impact on the Microbiome Sequencing Services Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Microbiome Sequencing Services Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Microbiome Sequencing Services Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by
Infinium Global Research on microbiome sequencing services market provides an
in-depth analysis of segments and sub-segments in the global as well as
regional microbiome sequencing services market. The study also highlights the
impact of drivers, restraints, and macro indicators on the global and regional
microbiome sequencing services market over the short term as well as long term.
The report is a comprehensive presentation of trends, forecast and dollar
values of global microbiome sequencing services market. According to the
report, the global microbiome sequencing services market is projected to grow
at a CAGR of 20.5% over the forecast period of 2018-2024.

Market Insight
A microbiome is the collection of
trillions of microorganisms that live on and in an individual’s body. This
microbiome lives on the skin, in the eyes, in the saliva & mouth, and rest
of the gastrointestinal tract. The study of the microbiome is to understand the
role of microbes in health and diseases. Microbiome plays an important role in
human health, immunity, and metabolism. Slightly modification in the configuration
of the microbiome can lead to diseases such as Crohn’s disease, asthma,
cardiovascular diseases, and irritable bowel syndrome. Therefore, microbiome
sequencing helps in understanding a wide range of diseases and treating them
further.
Increasing demand for
next-generation sequencing and increasing investment in microbiome research
drive the market growth for microbiome sequencing services market. Further,
growth in genomic research, drop in the cost of sequencing and flaring usage
area of microbiome sequencing boost the growth of this market. Additionally,
increasing consciousness regarding the benefits of the microbiome in cancer
development is one of the key trend fueling the demand for microbiome
sequencing services market. Increasing government funding and venture capitalist
in research and development of pharmaceutical and biotechnology, companies lead
the microbiome sequencing services. Rising occurrence of chronic diseases has
produced plenty of opportunity for the growth of this market in an upcoming
year. Whereas, the lack of professionals for interpreting data in this field is
likely to restrain this market growth. This sequencing generates a massive
amount of data that has to be construed using advanced software. Lack of
knowledge for advanced tools of data analysis among professionals may restrain market growth.
Among the geographies, North
America has accounted for the maximum share for microbiome sequencing services
market. Factors such as ease in availability of commercial solutions for
next-generation sequencing data analysis and government support with the help
of funds for genomics research drive the market growth in the North America
region. The Asia-Pacific is also projected to grow during the forecast period
due to increasing demand for next-generation sequencing for diagnosis and the
rising number of research studies.
Segment Covered
The report on global microbiome
sequencing services market covers segments such as technology, application, and
end user. On the basis of technology, the sub-markets include sequencing by
synthesis (SBS), sequencing by litigation (SBL), sanger sequencing, pyro sequencing,
targeted gene sequencing, short gun sequencing, and ran sequencing. On the
basis of application, the sub-markets include oncology, infectious diseases,
gastro-intestinal diseases, and CNS diseases. On the basis of an end user, the
sub-markets include pharmaceutical and biotechnology companies, and research
and academic institutes.
Geographic Coverage:
The report provides regional
analysis covering geographies such as North America, Europe, Asia-Pacific, and
Rest of the World. In this section, the key trends and market size for each
geography are provided over the period of 2016-2024. The countries covered in
the North America region include the U.S., Canada, and Mexico; while
Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among
others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included
in the European region. The U.S. drives the growth in the North America region
as it is the largest market in this region. The Asia-Pacific region offers
substantial potential for the market growth owing to rapid growth in markets
such as India and China.
Companies Profiled:
The report provides profiles of
the companies in the market such as uBiome, Inc., MR DNA, Microbiome Insights
Inc., Merieux NutriSciences Corporations, BaseClear B.V., Zymo Research Corp.,
Second Genome, Microbiome Therapeutics, LLC, EpiBiome, and Clinical
Microbiomics A/S.
Report Highlights:
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of microbiome sequencing services market. Moreover, the study
highlights current market trends and provides forecast from 2018-2024. We also
have highlighted future trends in the market that will affect the demand during
the forecast period. Moreover, the competitive analysis given in each regional
market brings an insight into the market share of the leading players.